These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 21906082)

  • 1. Absorption-dependent apparent volume of distribution at steady state (V(ss)/F) in pharmacokinetic data analysis.
    Soback S; Britzi M
    J Vet Pharmacol Ther; 2011 Oct; 34(5):512-4. PubMed ID: 21906082
    [No Abstract]   [Full Text] [Related]  

  • 2. Prediction of human pharmacokinetics using physiologically based modeling: a retrospective analysis of 26 clinically tested drugs.
    De Buck SS; Sinha VK; Fenu LA; Nijsen MJ; Mackie CE; Gilissen RA
    Drug Metab Dispos; 2007 Oct; 35(10):1766-80. PubMed ID: 17620347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mathematical comparison between volume of distribution (V) and volume of distribution at steady-state (Vss) utilizing model-independent approach.
    Sobol E; Bialer M
    Biopharm Drug Dispos; 2004 Mar; 25(2):99-101. PubMed ID: 14872558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A hybrid mixture discriminant analysis-random forest computational model for the prediction of volume of distribution of drugs in human.
    Lombardo F; Obach RS; Dicapua FM; Bakken GA; Lu J; Potter DM; Gao F; Miller MD; Zhang Y
    J Med Chem; 2006 Apr; 49(7):2262-7. PubMed ID: 16570922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction of human pharmacokinetics from animal data and molecular structural parameters using multivariate regression analysis: volume of distribution at steady state.
    Wajima T; Fukumura K; Yano Y; Oguma T
    J Pharm Pharmacol; 2003 Jul; 55(7):939-49. PubMed ID: 12906751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of gastrointestinal motility directly from human pharmacokinetic data.
    Roush JA
    Int J Pharm; 2011 Oct; 419(1-2):43-51. PubMed ID: 21784142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Critical analysis of the discrepancy between V(beta) and V(ss) for drugs exhibiting different two-compartment disposition profiles.
    Sobol E; Bialer M
    Biopharm Drug Dispos; 2005 Mar; 26(2):51-8. PubMed ID: 15614832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. On the determination of the time delay in reaching the steady state drug concentration in the organ compared to plasma.
    Berezhkovskiy LM
    J Pharm Sci; 2007 Dec; 96(12):3432-43. PubMed ID: 17628491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of pharmacokinetic and pharmacokinetic/pharmacodynamic modeling in drug discovery and development.
    Yu XQ; Wilson AG
    Future Med Chem; 2010 Jun; 2(6):923-8. PubMed ID: 21426110
    [No Abstract]   [Full Text] [Related]  

  • 10. Estimating human drug oral absorption kinetics from Caco-2 permeability using an absorption-disposition model: model development and evaluation and derivation of analytical solutions for k(a) and F(a).
    Usansky HH; Sinko PJ
    J Pharmacol Exp Ther; 2005 Jul; 314(1):391-9. PubMed ID: 15833900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction of volume of distribution at steady state in humans: comparison of different approaches.
    Zou P; Zheng N; Yang Y; Yu LX; Sun D
    Expert Opin Drug Metab Toxicol; 2012 Jul; 8(7):855-72. PubMed ID: 22591253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physiologically based pharmacokinetic (PBPK) modeling and simulation: applications in lead optimization.
    Peters SA; Ungell AL; Dolgos H
    Curr Opin Drug Discov Devel; 2009 Jul; 12(4):509-18. PubMed ID: 19562647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physiologically based approaches towards the prediction of pharmacokinetics: in vitro-in vivo extrapolation.
    De Buck SS; Mackie CE
    Expert Opin Drug Metab Toxicol; 2007 Dec; 3(6):865-78. PubMed ID: 18028030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetic changes in critical illness.
    Boucher BA; Wood GC; Swanson JM
    Crit Care Clin; 2006 Apr; 22(2):255-71, vi. PubMed ID: 16677999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A point estimator for the time course of drug release.
    Koehne-Voss S; Pigeot I
    Biom J; 2009 Feb; 51(1):146-58. PubMed ID: 19219906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measurement of binding of basic drugs to acidic phospholipids using surface plasmon resonance and incorporation of the data into mechanistic tissue composition equations to predict steady-state volume of distribution.
    Small H; Gardner I; Jones HM; Davis J; Rowland M
    Drug Metab Dispos; 2011 Oct; 39(10):1789-93. PubMed ID: 21764943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Computer simulation of blood level profiles. Drug liberation from two sustained-release preparations and computer simulation of single- and multiple-dose pharmacokinetics].
    Koch HP
    Pharmazie; 1992 Jul; 47(7):547-52. PubMed ID: 1518902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Physiologically based pharmacokinetics (PBPK).
    Espié P; Tytgat D; Sargentini-Maier ML; Poggesi I; Watelet JB
    Drug Metab Rev; 2009; 41(3):391-407. PubMed ID: 19601719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of in-vivo and in-silico methods used for prediction of tissue: plasma partition coefficients in rat.
    Graham H; Walker M; Jones O; Yates J; Galetin A; Aarons L
    J Pharm Pharmacol; 2012 Mar; 64(3):383-96. PubMed ID: 22309270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediction of the volume of distribution from in vitro data and use for estimating the absolute extent of absorption.
    Ritschel WA; Hammer GV
    Int J Clin Pharmacol Ther Toxicol; 1980 Jul; 18(7):298-316. PubMed ID: 7429676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.